COSENTYX 300MG INJ SOL PEP 1X2ML
Active ingredient: SEKUKINUMAB
View notice details →News topic
ATC group L04AC10
Current shortage notices for the ATC group L04AC10, structured by product, country and reporting period.
7 noticesCosentyx 150 mg inj. sol. s.c. pre-filled pen 2 x 1 ml
Active ingredient: Secukinumab
View notice details →COSENTYX 150MG INJ SOL PEP 2X1ML
Active ingredient: SEKUKINUMAB
View notice details →Cosentyx 300 mg inj. sol. s.c. pre-filled pen 3 x 2 ml
Active ingredient: Secukinumab
View notice details →COSENTYX 300MG INJ SOL PEP 1X2ML
Active ingredient: SEKUKINUMAB
View notice details →Cosentyx 300 mg inj. sol. s.c. pre-filled pen 3 x 2 ml
Active ingredient: Secukinumab
View notice details →Cosentyx 300 mg inj. opl. s.c. voorgev. pen 3 x 2 ml
Active ingredient: Secukinumab
View notice details →Plan supply. Connect sourcing and warehousing.
For pharmacies, wholesalers and manufacturers: choose the service matching your operational need.
Improve sourcing and supply availability
Researching this shortage professionally? We assess sourcing routes, suppliers and cross-border supply against your requirements. A notice does not confirm stock availability.
Send a sourcing enquiry →Pharma warehouse and pharmaceutical warehousing in Cheb
Medicine storage, batch and expiry control, picking and distribution for Germany and Europe. We agree the storage profile, temperature and capacity with you.
Request warehouse capacity →